Skip to main content

Table 2 Neurodevelopmental evaluation between study & control groups

From: The long-term neurodevelopmental outcomes of toddlers with SARS-CoV-2 infection in the neonatal period: a prospective observational study

 

Study Group

SARS-CoV-2 (+)

(n = 30)

Control Group

SARS-CoV-2 (-)

(n = 60)

P

MDI mean ± SDS

88.51 ± 8.33

89.56 ± 12.82

0.64

PDI mean ± SDS

89.13 ± 7.49

92.30 ± 7.22

0.05

NDI* Positivity n (%)

2 (6.6)

0

0.12

MDP n (%)

13 (43.3)

6 (10)

0.03

Blindness n (%)

0

0

NS

Deafness n (%)

0

0

NS

CP n (%)

0

0

NS

Need for Physical Therapy n (%)

1 (3.3)

0

0.33

Need for Special Education n (%)

1 (3.3)

0

0.33

  1. MDI- Mental developmental index, PDI- Psychomotor developmental index, NDI*- Neurodevelopmental retardation index defined as the presence of one or more of the following: (1) Moderate to severe cerebral palsy with functional losses, (2) Bilateral hearing loss and blindness, (3) Bayley-II MDI or PDI score < 70, MDP- Mildly delayed performance, defined as the presence of Bayley-II MDI or PDI score 70–84, CP - Cerebral palsy
Back to article page

Italian Journal of Pediatrics

ISSN: 1824-7288

Contact us